Anti-Programmed Cell Death Protein-1 Immunotherapy for Glioblastoma is Impaired by Systemic Chemotherapy but Enhanced in Combination With Locally Delivered Chemotherapy

Ehrlich Nathan A.; Zhang Ray R.; Kuo John S.

首页> 外文期刊>Neurosurgery >Anti-Programmed Cell Death Protein-1 Immunotherapy for Glioblastoma is Impaired by Systemic Chemotherapy but Enhanced in Combination With Locally Delivered Chemotherapy

【24h】

Anti-Programmed Cell Death Protein-1 Immunotherapy for Glioblastoma is Impaired by Systemic Chemotherapy but Enhanced in Combination With Locally Delivered Chemotherapy

机译：用于胶质母细胞瘤的抗程序性细胞死亡蛋白-1免疫疗法由全身化疗损害，但与局部递送的化疗组合增强

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Neurosurgery 》 |2017年第5期| 共3页
作者
Ehrlich Nathan A.; Zhang Ray R.; Kuo John S.;
展开▼
作者单位

Univ Wisconsin Madison Madison WI 53706 USA;

Univ Wisconsin Madison Madison WI 53706 USA;

Univ Wisconsin Madison Madison WI 53706 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类头部及神经外科学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Anti-Programmed Cell Death Protein-1 Immunotherapy for Glioblastoma is Impaired by Systemic Chemotherapy but Enhanced in Combination With Locally Delivered Chemotherapy [J] . Ehrlich Nathan A, Zhang Ray R, Kuo John S Clinical neurosurgery. . 2017 ,第5期

机译：胶质母细胞瘤的抗程序性细胞死亡蛋白1免疫疗法受到全身化学疗法的损害，但与局部递送的化学疗法相结合可得到增强
2. Anti-Programmed Cell Death Protein-1 Immunotherapy for Glioblastoma is Impaired by Systemic Chemotherapy but Enhanced in Combination With Locally Delivered Chemotherapy [J] . Ehrlich Nathan A., Zhang Ray R., Kuo John S. Neurosurgery . 2017 ,第5期

机译：用于胶质母细胞瘤的抗程序性细胞死亡蛋白-1免疫疗法由全身化疗损害，但与局部递送的化疗组合增强
3. Anti-Programmed Cell Death Protein-1 Immunotherapy for Glioblastoma is Impaired by Systemic Chemotherapy but Enhanced in Combination With Locally Delivered Chemotherapy [J] . Ehrlich Nathan A., Zhang Ray R., Kuo John S. Neurosurgery . 2017 ,第5期

机译：用于胶质母细胞瘤的抗程序性细胞死亡蛋白-1免疫疗法由全身化疗损害，但与局部递送的化疗组合增强
4. DEVELOPMENT OF THE MIXED MICELLES THAT DELIVER MULTIPLE DRUGS DOXORUBICIN (DOX) AND WORTMANNIN (WOR) SIMULTANEOUSLY FOR COMBINATION CANCER CHEMOTHERAPY [C] . Y. Bae, T. Diezi, A. Zhao, Controlled Release Society Annual Meeting and Exposition . 2007

机译：同时混合多种药物阿霉素（WOX）和渥曼青霉素（WOR）的混合胶束的开发
5. The effect of chemotherapy and Wilms' Tumor 1 silencing on glioblastoma cell death in-vitro. [D] . Chen, Mike Yue. 2007

机译：化学疗法和Wilms肿瘤1沉默对胶质母细胞瘤细胞体外死亡的影响。
6. Anti-Programmed Cell Death Protein-1 Immunotherapy for Glioblastoma is Impaired by Systemic Chemotherapy but Enhanced in Combination With Locally Delivered Chemotherapy [O] . Nathan A Ehrlich, Ray R Zhang, John S Kuo -1

机译：胶质母细胞瘤的抗程序性细胞死亡蛋白1免疫疗法受到全身化学疗法的损害但与局部递送的化学疗法相结合则得到增强
7. Phase I/II Trial of Combination of Temozolomide Chemotherapy and Immunotherapy With Fusions of Dendritic and Glioma Cells in Patients With Glioblastoma [O] . Wi Jin Kim, W. Christopher Newman, Nduka M. Amankulor 2017

机译：胶质瘤化疗和免疫疗法与胶质母细胞瘤患者的树突状和胶质瘤细胞融合的相互试验
8. Combinational Targeting of Prostate Carcinoma Cells and Tumors Associated Pericytes with Antibody Based Immunotherapy and Metronomic Chemotherapy [R] . Ferrone, S. 2010

机译：前列腺癌细胞和肿瘤相关周细胞的组合靶向与抗体免疫疗法和色素化疗

Anti-Programmed Cell Death Protein-1 Immunotherapy for Glioblastoma is Impaired by Systemic Chemotherapy but Enhanced in Combination With Locally Delivered Chemotherapy

著录项

相似文献

相关主题

期刊订阅